Logo image of XBP

XBP EUROPE HOLDINGS INC (XBP) Stock Fundamental Analysis

NASDAQ:XBP - Nasdaq - US98400V1017 - Common Stock

1.092  -0.01 (-0.73%)

Premarket: 1.09 0 (-0.18%)

Fundamental Rating

0

Taking everything into account, XBP scores 0 out of 10 in our fundamental rating. XBP was compared to 101 industry peers in the Financial Services industry. Both the profitability and financial health of XBP have multiple concerns. XBP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

XBP had negative earnings in the past year.
XBP had a negative operating cash flow in the past year.
XBP Yearly Net Income VS EBIT VS OCF VS FCFXBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M -4M -6M -8M -10M

1.2 Ratios

With a Return On Assets value of -14.85%, XBP is not doing good in the industry: 91.09% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.85%
ROE N/A
ROIC N/A
ROA(3y)-1.3%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XBP Yearly ROA, ROE, ROICXBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 40 60 80

1.3 Margins

XBP's Gross Margin of 24.14% is in line compared to the rest of the industry. XBP outperforms 49.51% of its industry peers.
The Profit Margin and Operating Margin are not available for XBP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XBP Yearly Profit, Operating, Gross MarginsXBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

XBP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XBP has been increased compared to 1 year ago.
The debt/assets ratio for XBP has been reduced compared to a year ago.
XBP Yearly Shares OutstandingXBP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M
XBP Yearly Total Debt VS Total AssetsXBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

XBP has an Altman-Z score of 0.98. This is a bad value and indicates that XBP is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 0.98, XBP is doing good in the industry, outperforming 60.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACCN/A
WACC9.78%
XBP Yearly LT Debt VS Equity VS FCFXBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.64 indicates that XBP may have some problems paying its short term obligations.
With a Current ratio value of 0.64, XBP is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
XBP has a Quick Ratio of 0.64. This is a bad value and indicates that XBP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.58, XBP is doing worse than 62.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.58
XBP Yearly Current Assets VS Current LiabilitesXBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

0

3. Growth

3.1 Past

XBP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.83%, which is quite impressive.
EPS 1Y (TTM)81.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XBP Yearly Revenue VS EstimatesXBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 50M 100M 150M
XBP Yearly EPS VS EstimatesXBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XBP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XBP Price Earnings VS Forward Price EarningsXBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

XBP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. XBP is more expensive than 62.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 76.46
XBP Per share dataXBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XBP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XBP EUROPE HOLDINGS INC

NASDAQ:XBP (1/21/2025, 8:00:02 PM)

Premarket: 1.09 0 (-0.18%)

1.092

-0.01 (-0.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.44%
Inst Owner Change0%
Ins Owners10.26%
Ins Owner Change0%
Market Cap32.95M
AnalystsN/A
Price TargetN/A
Short Float %0.94%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 76.46
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS5.07
BVpS-0.69
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.14%
FCFM N/A
ROA(3y)-1.3%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 35.64
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.58
Altman-Z 0.98
F-Score5
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A